Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004)
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux
- Status
- COMPLETED
- Phase
- PHASE3
Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)
- Status
- TERMINATED
- Phase
- PHASE2
NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b)
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Combination With Irinotecan- Erbitux
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.
- Status
- WITHDRAWN
- Phase
- PHASE2
Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
- Status
- TERMINATED
- Phase
- PHASE2